Rajala Rahul, Cleuren Audrey C A, Griffin Courtney T
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City (R.R., A.C.A.C., C.T.G.).
Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City (R.R., A.C.A.C., C.T.G.).
Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):53-71. doi: 10.1161/ATVBAHA.124.321353. Epub 2024 Oct 3.
The protease thrombin, which elicits multiple physiological and pathological effects on vascular endothelial cells (ECs), can signal through PARs (protease-activated receptors) 1 and 4. PAR1 is a high-affinity thrombin receptor known to signal on ECs, whereas PAR4 is a low-affinity thrombin receptor, and evidence for its expression and function on ECs is mixed. This study aims to exploit the high levels of thrombin generation and hepatic vascular dysfunction that occur during acetaminophen (APAP) overdose to determine (1) whether hepatic endothelial PAR4 is a functional receptor, and (2) the endothelial-specific functions for PAR1 and PAR4 in a high thrombin and pathological setting.
We generated mice with conditional deletion of in ECs and overdosed them with APAP. Hepatic vascular permeability, erythrocyte accumulation in the liver, thrombin generation, and liver function were assessed following overdose. Additionally, we investigated the expression levels of endothelial PARs and how they influence transcription in APAP-overdosed liver ECs using endothelial translating ribosome affinity purification followed by next-generation sequencing.
We found that mice deficient in high-expressing endothelial or low-expressing had equivalent reductions in APAP-induced hepatic vascular instability, although mice deficient for both receptors had lower vascular permeability at an earlier timepoint after APAP overdose than either of the single mutants. Additionally, mice with loss of both endothelial and had reduced thrombin generation after APAP overdose, suggesting decreased hypercoagulability. Last, we found that endothelial PAR1-but not PAR4-can regulate transcription in hepatic ECs.
Low-expressing PAR4 can react similarly to high-expressing PAR1 in APAP-overdosed hepatic ECs, demonstrating that PAR4 is a potent thrombin receptor. Additionally, these receptors are functionally redundant but act divergently in their expression and ability to influence transcription in hepatic ECs.
蛋白酶凝血酶对血管内皮细胞(ECs)具有多种生理和病理作用,可通过蛋白酶激活受体(PARs)1和4发出信号。PAR1是一种已知在ECs上发出信号的高亲和力凝血酶受体,而PAR4是一种低亲和力凝血酶受体,其在ECs上的表达和功能证据不一。本研究旨在利用对乙酰氨基酚(APAP)过量服用期间发生的高水平凝血酶生成和肝血管功能障碍,以确定(1)肝内皮PAR4是否为功能性受体,以及(2)在高凝血酶和病理环境中PAR1和PAR4的内皮特异性功能。
我们构建了ECs中条件性缺失的小鼠,并对其过量服用APAP。过量服用后评估肝血管通透性、肝脏中红细胞积聚、凝血酶生成和肝功能。此外,我们使用内皮翻译核糖体亲和纯化随后进行下一代测序,研究了内皮PARs的表达水平以及它们如何影响APAP过量服用的肝ECs中的转录。
我们发现,高表达内皮或低表达的缺陷小鼠在APAP诱导的肝血管不稳定性方面有同等程度的降低,尽管两种受体缺陷的小鼠在APAP过量服用后的较早时间点比任何一种单突变体的血管通透性都低。此外,内皮和均缺失的小鼠在APAP过量服用后凝血酶生成减少,提示高凝性降低。最后,我们发现内皮PAR1而非PAR4可调节肝ECs中的转录。
在APAP过量服用的肝ECs中,低表达的PAR4与高表达的PAR1反应相似,表明PAR4是一种有效的凝血酶受体。此外,这些受体在功能上是冗余的,但在其表达以及影响肝ECs转录的能力方面表现不同。